Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-014705
Filing Date
2015-02-17
Accepted
2015-02-17 18:03:11
Documents
1
Period of Report
2015-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4102
  Complete submission text file 0001209191-15-014705.txt   5492
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Ho Peter Tai-Ching (Reporting) CIK: 0001619052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 15624842